As of 2024-12-12, the Relative Valuation of Ligand Pharmaceuticals Inc (LGND) is 95.29 USD. This relative valuation is based on P/E multiples. With the latest stock price at 120.36 USD, the upside of Ligand Pharmaceuticals Inc based on Relative Valuation is -20.8%.
The range of the Relative Valuation is 69.91 - 112.94 USD.
| Range | Selected | |
| Trailing P/E multiples | 37.8x - 47.2x | 42.5x |
| Forward P/E multiples | 25.0x - 38.6x | 31.8x |
| Fair Price | 69.91 - 112.94 | 95.29 |
| Upside | -41.9% - -6.2% | -20.8% |
| Date | P/E |
| 2024-12-10 | 49.54 |
| 2024-12-09 | 48.60 |
| 2024-12-06 | 52.15 |
| 2024-12-05 | 51.59 |
| 2024-12-04 | 50.54 |
| 2024-12-03 | 50.10 |
| 2024-12-02 | 51.26 |
| 2024-11-29 | 50.74 |
| 2024-11-27 | 51.19 |
| 2024-11-26 | 51.94 |
| 2024-11-25 | 50.39 |
| 2024-11-22 | 49.79 |
| 2024-11-21 | 48.69 |
| 2024-11-20 | 46.60 |
| 2024-11-19 | 46.70 |
| 2024-11-18 | 46.65 |
| 2024-11-15 | 46.67 |
| 2024-11-14 | 48.23 |
| 2024-11-13 | 51.00 |
| 2024-11-12 | 50.44 |
| 2024-11-11 | 51.58 |
| 2024-11-08 | 50.65 |
| 2024-11-07 | 54.26 |
| 2024-11-06 | 48.83 |
| 2024-11-05 | 46.42 |
| 2024-11-04 | 46.04 |
| 2024-11-01 | 45.97 |
| 2024-10-31 | 44.15 |
| 2024-10-30 | 45.87 |
| 2024-10-29 | 48.26 |
| 2024-10-28 | 47.36 |
| 2024-10-25 | 46.71 |
| 2024-10-24 | 46.36 |
| 2024-10-23 | 44.65 |
| 2024-10-22 | 44.49 |
| 2024-10-21 | 44.61 |
| 2024-10-18 | 44.44 |
| 2024-10-17 | 44.23 |
| 2024-10-16 | 44.76 |
| 2024-10-15 | 43.61 |
| 2024-10-14 | 43.22 |
| 2024-10-11 | 43.00 |
| 2024-10-10 | 41.91 |
| 2024-10-09 | 43.13 |
| 2024-10-08 | 43.01 |
| 2024-10-07 | 42.87 |
| 2024-10-04 | 43.77 |
| 2024-10-03 | 42.71 |
| 2024-10-02 | 41.75 |
| 2024-10-01 | 42.34 |